Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

L
La Greca, Francesca

Università Campus Biomedico di Roma
(P 70) EPIDEMIOLOGY AND POTENTIAL CLINICAL RELEVANCE OF CONTACTIN-4 EXPRESSION IN SOFT TISSUE SARCOMA
Francesca La Greca
Favorite
López Sanmartín, Consol

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Consol López Sanmartín
Favorite
Labib, Ramy

University of Miami Miller School of Medicine, Department of Orthopaedic Surgery
(P 94) EFFECT OF POSTOPERATIVE PHYSICAL THERAPY ON FUNCTIONAL OUTCOMES FOLLOWING MUSCULOSKELETAL TUMOR RESECTION
Ramy Labib
Favorite
Laetsch, Theodore

The Children’s Hospital of Philadelphia, University of Pennsylvania
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Theodore Laetsch
Favorite
(P 262) EVALUATING FRONT-LINE THERAPY ACCORDANCE WITH CURRENT SYNOVIAL SARCOMA GUIDELINES
Theodore Laetsch
Favorite
(P 263) DESCRIBING THE CHARACTERISTICS AND TREATMENT OF SYNOVIAL SARCOMA IN THE RECURRENT SETTING
Theodore Laetsch
Favorite
Laetsch, Theodore

The Children’s Hospital of Philadelphia, University of Pennsylvania Philadelphia
(P 417) EFFICACY AND SAFETY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SARCOMAS
Theodore Laetsch
Favorite
(P 419) PROSPECTIVE REAL-WORLD STUDY OF LAROTRECTINIB (LARO) IN PATIENTS (PTS) WITH TRK FUSION SOLID TUMORS: INTERIM ANALYSIS OF ON-TRK
Theodore Laetsch
Favorite
Laetsch, Theodore

The Children’s Hospital of Philadelphia, University of Pennsylvania
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Theodore Laetsch
Favorite
Lagmay, Joanne

University of Florida
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Joanne Lagmay
Favorite
Laitinen, Minna

Helsinki University Hospital
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Minna Laitinen
Favorite
Lalli, Narinder

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Narinder Lalli
Favorite
Lam, Alexander

University of California, San Francisco
(P 439) AN OPEN LABEL MULTICENTER PHASE 2 STUDY WITH SAFETY LEAD IN OF INTRATUMORAL VUSOLIMOGENE ODERPAREPVEC IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH ANGIOSARCOMA
Alexander Lam
Favorite
Lammers, Marshall

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Marshall Lammers
Favorite
Lammers, Marshall

mlammers@ucdavis.edu
(P 245) SUBTYPE SPECIFIC CHARACTERIZATION OF IMMUNE INFILTRATION IN SOFT TISSE SARCOMAS
Marshall Lammers
Favorite
Landers, Sharon

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Sharon Landers
Favorite
Landreth, Kaitlyn

West Virginia University School of Medicine, Department of Microbiology, Immunology, and Cell Biology
(P 30) MYELOPEROXIDASE AS A POTENTIAL THERAPEUTIC TARGET IN SOFT TISSUE SARCOMA
Kaitlyn Landreth
Favorite
Langfitt, Deanna

St. Jude Children's Research Hospital
(P 241) MACROPHAGE INHIBITION ENHANCES PERIPHERAL CAR T CELL EXPANSION AND TUMOR CONTROL IN A PATIENT-DERIVED HUMANIZED MODEL OF AUTOLOGOUS CAR T CELL EFFICACY IN PEDIATRIC OSTEOSARCOMA (OS)
Deanna Langfitt
Favorite
Lansu, Jules

Haga Hospital, The Hague, The Netherlands
(P 295) FROM HISTORICAL REFERENCE TO MODERN PRACTICE: WOUND COMPLICATION RATES IN SOFT TISSUE SARCOMA TREATED WITH RADIOTHERAPY ACROSS ERAS
Jules Lansu
Favorite
LaQuaglia, Michael

Memorial Sloan Kettering Cancer Center
(P 265) MULTI-SITE SINGLE CELL TRANSCRIPTOMICS REVEAL DISTINCT IMMUNE INFILTRATIVE PATTERNS IN DESMOPLASTIC SMALL ROUND CELL TUMOR
Michael LaQuaglia
Favorite
Lara, Daniela

Fundación Colombiana de Cancerología Clínica Vida
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Daniela Lara
Favorite
Larson, Aubriannah

University of Iowa Health Care
(P 370) CLINICAL OUTCOMES OF CUTANEOUS UNDIFFERENTIATED PLEOMORPHIC SARCOMA AND SUBCUTANEOUS MYXOFIBROSARCOMA: A RETROSPECTIVE REVIEW
Aubriannah Larson
Favorite
Larson, Reece C.

University of Florida
(P 129) HIJACKED FUEL: GLYCOGEN-DRIVEN METABOLIC SHIFTS IN IDH1-MUTANT CHONDROSARCOMA
Reece C. Larson
Favorite
Lasa Laborda, Adriana

Hospital Santa Creu i Sant Pau
(P 218) THE IMPACT OF BROADENED GENETIC COUNSELLING REFERRAL CRITERIA IN SARCOMA PATIENTS: A REFERENCE CENTRE'S EXPERIENCE
Adriana Lasa Laborda
Favorite
Laskar, Siddhartha

Tata Memorial Hospital, Mumbai
(P 286) INTERSTITIAL BRACHYTHERAPY FOR ORGAN AND FUNCTION PRESERVATION IN SOFT TISSUE SARCOMAS: LONG TERM OUTCOMES
Siddhartha Laskar
Favorite
(P 292) CRANIOVERTEBRAL EWINGS SARCOMA WITH MENINGEAL INFILTRATION - A CLINICAL OUTCOME ANALYSIS
Siddhartha Laskar
Favorite
(P 387) TREATMENT PATTERNS AND PROGNOSTIC FACTORS IN LOCALISED SYNOVIAL SARCOMA: A RETROSPECTIVE STUDY FROM A TERTIARY CANCER CENTRE IN INDIA
Siddhartha Laskar
Favorite
(P 438) RANDOMIZED, OPEN-LABEL, PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY VERSUS OBSERVATION IN NON-METASTATIC, HIGH-RISK SOFT TISSUE SARCOMAS (ACO-SARC TRIAL)
Siddhartha Laskar
Favorite
Lasky, Joseph

Cure 4 The Kids Foundation
(P 261) SUSTAINED RESPONSE WITH RIVOCERANIB AND DENOSUMAB IN RELASPED OSTEOSARCOMA
Joseph Lasky
Favorite
Lau, Chelsea

Northwestern Medicine
(P 373) COMPLETE RESPONSE TO FRONT-LINE PEXIDARTINIB IN SYMPTOMATIC TEMPOROMANDIBULAR JOINT TENOSYNOVIAL GIANT CELL TUMOR
Chelsea Lau
Favorite
Lau, Chelsea

Northwestern University Feinberg School of Medicine
(P 429) SINGLE-ARM, OPEN-LABEL PHASE II TRIAL OF XL092 (ZANZALINTINIB) IN PATIENTS WITH ADVANCED LEIOMYOSARCOMA: TRIAL IN PROGRESS
Chelsea Lau
Favorite
Lauretta, Andrea

Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
(P 328) INNOVATING SARCOMA EDUCATION: EARLY OUTCOMES OF THE ITALIAN SOCIETY OF SURGICAL ONCOLOGY (SICO) SARCOMA SOCIAL MULTI-PLATFORM JOURNAL CLUB INITIATIVE
Andrea Lauretta
Favorite
Lawlor, Elizabeth

Seattle Children's Research Institute
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Elizabeth Lawlor
Favorite
(P 256) THE SEAN KARL COHORT: A NATIONAL COLLABORATIVE SINGLE-CELL RNASEQ STUDY OF PAIRED PATIENT EWING SARCOMA SPECIMENS
Elizabeth Lawlor
Favorite
(P 260) MECHANISM AND EFFICACY OF ANTHRACYCLINE MEDIATED EPIGENETIC DISRUPTION IN BONE SARCOMAS.
Elizabeth Lawlor
Favorite
Lawrenz, Joshua

Vanderbilt University Medical Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Joshua Lawrenz
Favorite
Lawrenz, Joshua

Division of Musculoskeletal Oncology, Department of Orthopaedic Surgery, Vanderbilt University Medical Center
(P 85) MAKING NEGATIVE MARGIN MUSCULOSKELETAL TUMOR SURGERY A VIRTUAL REALITY USING 3D SPECIMEN SCANNING
Joshua Lawrenz
Favorite
Lawrenz, Joshua

Vanderbilt University Medical Center
(P 97) RISK FACTORS ASSOCIATED WITH AMPUTATION VERSUS CONTINUED LIMB SALVAGE IN LOWER EXTREMITY ENDOPROSTHETIC RECONSTRUCTION
Joshua Lawrenz
Favorite
Lazar, Alexander

MD Anderson Cancer Center
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Alexander Lazar
Favorite
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Alexander Lazar
Favorite
(P 54) PRECLINICAL MODELS REVEALING MDM2-P53 INTERACTION AND DEPENDENCY FOR TUMOR CELL SURVIVAL IN WELL-DIFFERENTIATED (WD) AND DEDIFFERENTIATED (DD) LIPOSARCOMA (LPS).
Alexander Lazar
Favorite
(P 172) COMPARISON OF CELL SEGMENTATION METHODS IN SOFT TISSUE SARCOMA (STS) SPATIAL PROTEOMIC DATASETS
Alexander Lazar
Favorite
(P 184) MTAP IN GASTROINTESTINAL STROMAL TUMOR (GIST): RATE OF MTAP LOSS AND CONCORDANCE BETWEEN GENOMIC SEQUENCING AND IMMUNOHISTOCHEMISTRY
Alexander Lazar
Favorite
(P 242) IMMUNE PROFILING OF UNDIFFERENTIATED PLEOMORPHIC SARCOMAS REVEALS DISTINCT PROGNOSTIC SUBGROUPS
Alexander Lazar
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Alexander Lazar
Favorite
Lazarides, Alexander

Moffitt Cancer Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Alexander Lazarides
Favorite
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
Alexander Lazarides
Favorite
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
Alexander Lazarides
Favorite
(P 138) A MULTI-INSTITUTIONAL ARCHIVE AND DEEP LEARNING PIPELINE FOR QUANTIFYING CHONDROSARCOMA COMPOSITION
Alexander Lazarides
Favorite
(P 140) REFINING PRE-SURGICAL ASSESSMENT OF LONG-BONE CHONDROSARCOMA THROUGH THE RADIOLOGIC AGGRESSIVENESS SCORE
Alexander Lazarides
Favorite
(P 141) A RETROSPECTIVE ANALYSIS OF THE BIRMINGHAM ATYPICAL CARTILAGE TUMOUR IMAGING PROTOCOL (BACTIP) IN MANAGING CENTRAL CARTILAGE TUMORS OF THE LONG BONES
Alexander Lazarides
Favorite
(P 142) ARE THERE INDEPENDENT PREDICTORS OF DEDIFFERENTIATED CHONDROSARCOMA ON MAGNETIC RESONANCE IMAGING? A MULTIVARIATE ANALYSIS
Alexander Lazarides
Favorite
(P 145) PATHOLOGIC FRACTURE IN CHONDROSARCOMA OF LONG BONES: A RETROSPECTIVE COHORT STUDY
Alexander Lazarides
Favorite
(P 160) A COMPARATIVE ANALYSIS OF DEDIFFERENTIATED AND CONVENTIONAL CHONDROSARCOMA OUTCOMES
Alexander Lazarides
Favorite
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
Alexander Lazarides
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Alexander Lazarides
Favorite
(P 453) OUTCOMES OF PLEOMORPHIC LIPOSARCOMA PATIENTS FOLLOWING MULTI-DISCIPLINARY MANAGEMENT WITHIN A TERTIARY CANCER CENTER
Alexander Lazarides
Favorite
Le Cesne, Axel

International Department, Gustave Roussy Institute
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Axel Le Cesne
Favorite
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Axel Le Cesne
Favorite
(P 422) EFFICACY WITH VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT) AND PRIOR COLONY-STIMULATING FACTOR 1 (CSF1) INHIBITOR THERAPY: A PHASE 2 CASE SERIES
Axel Le Cesne
Favorite
Le Grange, Franel

University College London Hospitals
(P 281) LOCAL CONTROL WITH MODERATELY HYPOFRACTIONATED DEFINITIVE RADIOTHERAPY DELIVERED WITH A SIMULTANEOUS INTEGRATED BOOST TECHNIQUE TO NON-EXTREMITY SOFT TISSUE AND BONE SARCOMAS
Franel Le Grange
Favorite
Le loarer, François

Institut Bergonié
(P 324) FULLY MATURE TERTIARY LYMHOID STRUCTURES AS PREDICTORS OF LOCAL RECURRENCE IN SOFT TISSUE SARCOMAS
François Le loarer
Favorite
le Pechoux, Cecile

Gustave Roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Cecile le Pechoux
Favorite
Leavey, Patrick

UT Southwestern Medical Center
(P 168) LEVERAGING LARGE LANGUAGE MODELS FOR STRUCTURED INFORMATION EXTRACTION FROM EWING SARCOMA PATHOLOGY REPORTS
Patrick Leavey
Favorite
LeBlanc, Amy

National Institutes of Health
(P 258) INVESTIGATING THE ROLE OF ALVEOLAR PNEUMOCYTES IN THE LUNG MICROENVIRONMENT OF OSTEOSARCOMA METASTASES
Amy LeBlanc
Favorite
Leddy, Lee

Medical University of South Carolina
(P 279) IMPACT OF PREOPERATIVE 5-DAY HYPOFRACTIONATED RADIOTHERAPY (HFRT) FOR SOFT TISSUE SARCOMA (STS) ON BARRIERS TO TREATMENT AT A HIGH-VOLUME SARCOMA CENTER (HV-SC)
Lee Leddy
Favorite
Ledo Hopgood, Paula

University of Miami, Miller School of Medicine
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
Paula Ledo Hopgood
Favorite
Lee, Bohae

University of Iowa Hospitals and Clinics
(P 343) PROGRESSION FREE SURVIVAL OF IMMUNE CHECKPOINT INHIBITORS IN THE FIRST-LINE TREATMENT OF METASTATIC SARCOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS.
Bohae Lee
Favorite
Lee, Byrne

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Byrne Lee
Favorite
Lee, Chao-Tung

National Health Research Institute
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Chao-Tung Lee
Favorite
Lee, Dean

Nationwide Children's Hospital
(P 254) EOSINOPHILIC FASCIITIS (EF) AS A COMPLICATION OF NATURAL KILLER (NK) CELL-BASED IMMUNOTHERAPY IN A YOUNG ADULT WITH RECURRENT METASTATIC EWING SARCOMA
Dean Lee
Favorite
Lee, Grace

University of Michigan
(P 52) VALIDATION OF SYNGENEIC MURINE DEDIFFERENTIATED LIPOSARCOMA MODELS FOR PRECLINICAL EVALUATION OF THERAPEUTIC SENSITIVITY
Grace Lee
Favorite
Lee, Jewoo

Department of Orthopaedic Surgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Jewoo Lee
Favorite
lee, JISOO

Department of Orthopaedic Surgery, Seoul National University Bundang Hospital
(P 66) ARHGEF4 EXPRESSION IN SOFT TISSUE SARCOMA CORRELATES WITH LOCAL GROWTH PATTERN: WHOLE TRANSCRIPTOME SEQUENCING ON SPATIALLY SEPARATED REGIONS, PATIENT-DERIVED MODELS, AND ORTHOTOPIC IN VIVO ANALYSIS
JISOO lee
Favorite
Lee, Ming-Jing

National Taiwan University Hospital Hsin-Chu Branch
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Ming-Jing Lee
Favorite
Lee, Minpyo

Department of Orthopaedic Surgery, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Minpyo Lee
Favorite
Leeper, Haley

Oregon State University
(P 19) SERUM EXOSOMES IDENTIFY AN ABERRANT PROTEOMIC SIGNATURE IN CANINE OSTEOSARCOMA PRECEDING METASTATIC PROGRESSION
Haley Leeper
Favorite
Lee, Sean

Tulane University
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Sean Lee
Favorite
Lee, Seungjun

Boston University Chobanian and Avedisian School of Medicine
(P 205) CENTRALIZATION OF SARCOMA CARE IMPROVES OUTCOMES DESPITE POORER PRESENTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Seungjun Lee
Favorite
Lee, Soobin

Seoul National University
(P 175) INTERPRETABLE DEEP LEARNING BASED CLASSIFICATION OF SARCOMA IMMUNE SUBTYPES FROM H&E SLIDES FOR IMMUNOTHERAPY STRATIFICATION
Soobin Lee
Favorite
Lee, Stella

University of Pittsburgh Medical Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Stella Lee
Favorite
Lee, Suyeon

National Cancer Center
(P 109) FINITE ELEMENT ANALYSIS FOR FIXATION EVALUATION OF PATIENT-SPECIFIC ORTHOPEDIC IMPLANTS
Suyeon Lee
Favorite
Lee, Yeh Chen

Prince of Wales Hospital
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Yeh Chen Lee
Favorite
Lee, Yong-Suk

Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
(P 171) THREE-DIMENSIONAL DEEP LEARNING MODEL FOR PREDICTING PROXIMAL FEMORAL PATHOLOGIC FRACTURE USING OPPORTUNISTIC ABDOMINOPELVIC CT IN PATIENTS WITH ADVANCED CANCER: A PRELIMINARY REPORT
Yong-Suk Lee
Favorite
Lee, Yu Na

National Cancer Center
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Yu Na Lee
Favorite
Lefler, Daniel

University of Pennsylvania
(P 185) CANCER TESTIS ANTIGENS AS TARGETS IN KIT11-MUTATED, IMATINIB-RESISTANT GIST
Daniel Lefler
Favorite
Leite, Luis

Universidade Federal Fluminense
(P 347) SURVIVAL ANALYSIS AND PROGNOSTIC FACTORS OF SOFT TISSUE SARCOMAS OF THE TRUNK AND EXTREMITIES TREATED BETWEEN 2010 AND 2015: EXPERIENCE OF THE BRAZILIAN NATIONAL CANCER INSTITUTE
Luis Leite
Favorite
Leithner, Andreas

Medical University of GrazDept of Orthopaedics and Trauma, Medical University of Graz
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Andreas Leithner
Favorite
Lekberg, Tobias

Karolinska Hospital and Institute
(P 270) FEASIBILITY OF FERTILITY PRESERVATION IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH SARCOMAS - A PROSPECTIVE COHORT STUDY WITH LONG-TERM FOLLOW-UP
Tobias Lekberg
Favorite
Lemieux, Christopher

Service d'Hémato-oncologie, CHU de Québec-Université Laval, Québec, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Christopher Lemieux
Favorite
Lemos Ballester, Pedro

The Hospital for Sick Children
(P 73) TARGETABLE GENE DEPENDENCIES IN EWING SARCOMA SUBTYPES
Pedro Lemos Ballester
Favorite
Le, Ngan

UNC
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Ngan Le
Favorite
Lennerz, Jochen

Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital and Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Jochen Lennerz
Favorite
Leonard, Hugh

EHE Rare Cancer Charity (UK)
(P 446) GDF-15 AS A PROGNOSTIC FACTOR IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA
Hugh Leonard
Favorite
(P 447) PAIN ASSESSMENT CRITERIA (PAC) ANTICIPATE RECIST PROGRESSION AND CORRELATE WITH BLOOD LEVELS OF GROWTH DIFFERENTIATION FACTOR 15 (GDF15) IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE)
Hugh Leonard
Favorite
Leoni, Mollie

Kura Oncology, Inc.
(P 423) ZIFTOMENIB IN COMBINATION WITH IMATINIB IN ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) AFTER IMATINIB FAILURE: PHASE 1A/B STUDY OF SAFETY, PHARMACOKINETICS, AND ANTITUMOR ACTIVITY
Mollie Leoni
Favorite
Lerman, Daniel

St. Luke's Medical Center
(P 106) REPAIR: A PRELIMINARY REPORT ON AN ONGOING MULTI-CENTER TRIAL FOR PATIENTS UNDERGOING SURGICAL STABILIZATION FOR METASTATIC BONE DISEASE OF THE FEMUR
Daniel Lerman
Favorite
Letson, Doug

Moffitt Cancer Center
(P 84) A MULTICENTER COMPARISON OF REVERSE TOTAL SHOULDER ARTHROPLASTY VERSUS HEMIARTHROPLASTY FOR ENDOPROSTHETIC RECONSTRUCTION FOLLOWING ONCOLOGIC RESECTION OF THE PROXIMAL HUMERUS
Doug Letson
Favorite
(P 102) FACTORS RELATED TO ASEPTIC LOOSENING IN ENDOPROSTHESIS RECONSTRUCTION OF THE PROXIMAL TIBIA
Doug Letson
Favorite
(P 114) DENOSUMAB THERAPY AND MIRELS ADJUSTED ODDS OF PATHOLOGIC FRACTURE OR PROPHYLACTIC STABILIZATION IN APPENDICULAR SKELETAL METASTASES
Doug Letson
Favorite
(P 163) CHONDROSARCOMA IN THE AYA POPULATION
Doug Letson
Favorite
Levin, Adam

Johns Hopkins University
(P 222) DO WE ALL SEE IT THE SAME: AN INTER-RATER RELIABILITY ANALYSIS OF THE MUSCULOSKELETAL TUMOR REGISTRY DATA ELEMENTS
Adam Levin
Favorite
(P 345) SARCOMA BIOPSY COMPARISON BETWEEN REFERRAL CENTERS AND TREATING CENTERS: THE MUSCULOSKELETAL TUMOR REGISTRY (MSTR) EXPERIENCE
Adam Levin
Favorite
levy, Antonin

Gustave Roussy
(P 299) RECURRENCES AFTER PRIMARY RPS SURGERY IN A HIGH-VOLUME SARCOMA CENTER: A RETROSPECTIVE ANALYSIS ON 402 PATIENTS
Antonin levy
Favorite
Levy, Tyler

Cell Signaling Technology
(P 198) EXPLOITING METABOLIC DYSREGULATION IN SUCCINATE DEHYDROGENASE-DEFICIENT GASTROINTESTINAL STROMAL TUMOR
Tyler Levy
Favorite
Lewandowski, Sara

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Sara Lewandowski
Favorite
Lewin, Jeremy

Peter MacCallum Cancer Centre
(P 121) REAL-WORLD EXPERIENCE OF CABOZANTINIB MONOTHERAPY IN RELAPSED OR REFRACTORY OSTEOSARCOMA AND EWING SARCOMA: A SINGLE-CENTRE AUSTRALIAN STUDY
Jeremy Lewin
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Jeremy Lewin
Favorite
(P 344) REAL-WORLD EXPERIENCE OF SORAFENIB IN DESMOID TUMOURS: A SINGLE-CENTRE AUSTRALIAN STUDY
Jeremy Lewin
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Jeremy Lewin
Favorite
Liang, Jiahao

University of Miami
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
Jiahao Liang
Favorite
Li, Annie

Department of Pathology, Massachusetts General Hospital, Harvard Medical School
(P 45) MONITORING EWSR1 FUSIONS IN SARCOMA PATIENTS USING PERSONALIZED LIQUID BIOPSY ASSAYS
Annie Li
Favorite
Liapis, Evangelos

Center for Discovery and Innovation, Hackensack Meridian Health
(P 251) SPATIAL MULTI-OMIC ANALYSIS OF RHABDOMYOSARCOMA IDENTIFIES THERAPEUTIC VULNERABILITIES
Evangelos Liapis
Favorite
Li, Cheng-Peng

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing); Sarcoma Center
(P 165) EVALUATING LARGE LANGUAGE MODELS AS DECISION SUPPORT TOOLS IN MULTIDISCIPLINARY TUMOR BOARDS FOR GASTROINTESTINAL STROMAL TUMORS
Cheng-Peng Li
Favorite
(P 169) BENCHMARKING LARGE LANGUAGE MODELS VS MULTIDISCIPLINARY TUMOR BOARDS OF 21 SARCOMA CENTERS
Cheng-Peng Li
Favorite
Lid, Ana

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Ana Lid
Favorite
Li, Duan

Memorial Sloan Kettering Cancer Center
(P 421) CHARACTERIZING THE IMMUNE RESPONSE TO INTRATUMORAL TIGILANOL TIGLATE (TT) IN PATIENTS WITH ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS) IN A PHASE IIA TRIAL (NCT05755113)
Duan Li
Favorite
Lieb, Camryn

Genesis Research Group
(P 464) EFFICACY OUTCOMES AMONG PATIENTS WITH ADVANCED EPITHELIOID SARCOMAS OF PROXIMAL-TYPE AND DISTAL-TYPE TREATED WITH TAZ: POST HOC ANALYSIS OF STUDY EZH-202
Camryn Lieb
Favorite
Liebner, David

The Ohio State University Comprehensive Cancer Center
(P 161) CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF CHONDROSARCOMA: A SINGLE-INSTITUTIONAL EXPERIENCE
David Liebner
Favorite
(P 170) GEMSARC: AN AI BASED PREDICTIVE GENE SIGNATURE FOR GEMCITABINE EFFICACY IN ADVANCED SOFT-TISSUE SARCOMAS
David Liebner
Favorite
(P 335) OUTCOMES OF TALIMOGENE LAHERPAREPVEC IN SOFT TISSUE SARCOMA
David Liebner
Favorite
(P 408) REAL-WORLD SINGLE-CENTER INSIGHTS INTO CT-DNA DYNAMICS ACROSS SOFT TISSUE SARCOMAS
David Liebner
Favorite
Lietz, Christopher

Massachusetts General Hospital
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Christopher Lietz
Favorite
Li, Evelyn

Tom Baker Cancer Center, University of Calgary, Calgary, Alberta, Canada
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Evelyn Li
Favorite
Li, George

Memorial Sloan Kettering Cancer Center
(P 409) RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS INCLUDING HLA GENOTYPE IN MYXOID LIPOSARCOMA
George Li
Favorite
Ligon, John

University of Florida
(P 248) AN EX VIVO ASSAY TO PREDICT IMMUNOTHERAPY RESPONSE IN SARCOMA
John Ligon
Favorite
(P 426) A PHASE I/II TRIAL USING RNA LIPID NANOPARTICLES FOR RECURRENT OSTEOSARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
John Ligon
Favorite
Li, Jia

Ipsen, Cambridge, MA, USA
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Jia Li
Favorite
Li, Jian

Department of Gastrointestinal Oncology, Beijing Cancer Hospital
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Jian Li
Favorite
Lillemoe, Heather

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Heather Lillemoe
Favorite
Lilley, Elizabeth

Brigham and Women's Hospital
(P 228) FREQUENCY AND CLARITY OF SURGICAL GOALS FOR TUMOR RESECTION IN ADVANCED SARCOMA
Elizabeth Lilley
Favorite
Li, Luyuan

North Alabama Medical Center
(P 117) THERAPEUTIC POTENTIAL OF DOXORUBICIN AND DASATINIB COMBINATION IN OSTEOSARCOMA
Luyuan Li
Favorite
(P 148) CHARACTERISTICS AND OUTCOMES OF CHONDROSARCOMA PATIENTS TREATED WITH PROTON THERAPY: A SYSTEMATIC REVIEW OF PUBLISHED SERIES
Luyuan Li
Favorite
Lim, Hyun-ju

National Cancer Center
(P 296) PULMONARY CEMENT EMBOLISM ASSOCIATED WITH PERCUTANEOUS CEMENTOPLASTY FOR BONE METASTASIS: MECHANISMS AND PROTECTIVE FACTORS
Hyun-ju Lim
Favorite
Lim, Tse Hui

Singapore General Hospital
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Tse Hui Lim
Favorite
Lim, Vivian Yujing

A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB)
(P 53) ESTABLISHMENT AND CHARACTERISATION OF LIPOSARCOMA-DERIVED CELLS AS RELEVANT PRE-CLINICAL MODELS FOR TARGET DISCOVERY
Vivian Yujing Lim
Favorite
Lin, Adrian

David Geffen School of Medicine at University of California Los Angeles
(P 16) MITOCHONDRIAL GENETIC VARIATION ORCHESTRATES COPZ1 TRANSCRIPT HETEROGENEITY AND REVEALS TELOMERE-MEDIATED VULNERABILITIES IN OSTEOSARCOMA
Adrian Lin
Favorite
(P 72) COUNTY-LEVEL ASSOCIATIONS BETWEEN AIRBORNE TOXICANT EMISSIONS AND EWING SARCOMA DIAGNOSIS IN THE UNITED STATES
Adrian Lin
Favorite
(P 81) ASSESSING PROGNOSTIC FACTORS OF CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH MALIGNANT GIANT CELL TUMORS: A POPULATION BASED STUDY FROM THE SEER DATABASE
Adrian Lin
Favorite
(P 92) PRIMARY TUMOR SIZE AS AN INDEPENDENT PROGNOSTIC FACTOR IN OSTEOSARCOMA: PROPENSITY SCORE-MATCHED ANALYSIS DEMONSTRATES A CONTINUOUS DOSE-RESPONSE RELATIONSHIP
Adrian Lin
Favorite
(P 100) THE ROLE OF CANCER TYPE IN THE DEVELOPMENT OF PERIPROSTHETIC JOINT INFECTION IN DISTAL FEMORAL REPLACEMENT
Adrian Lin
Favorite
(P 107) IS THERE A BETTER OPTION: INTRAMEDULLARY NAIL VERSUS PLATE OSTEOSYNTHESIS FOR PATHOLOGIC HUMERAL FRACTURES?
Adrian Lin
Favorite
(P 108) DISTANCE WEIGHTED MATCHING IN THE QUANTIFICATION OF EXCESS MORBIDITY IN EXTERNAL HEMIPELVECTOMY AND HIP DISARTICULATION
Adrian Lin
Favorite
(P 157) INCOME IMPACTS OVERALL BUT NOT CAUSE-SPECIFIC SURVIVAL IN PATIENTS WITH CHONDROSARCOMA: A POPULATION BASED STUDY FROM THE SEER DATABASE
Adrian Lin
Favorite
(P 232) IS THERE A ROLE FOR POSITRON EMISSION TOMOGRAPHY IN THE STAGING OF LANGERHANS CELL HISTIOCYTOSIS?
Adrian Lin
Favorite
(P 384) PELVIC LOCATION PREDICTS WORSE OUTCOMES IN ALVEOLAR RHABDOMYOSARCOMA: UNDERUSE OF RADIOTHERAPY AND MISSED SURVIVAL BENEFIT
Adrian Lin
Favorite
Linder-Stragliotto, Christina

Karolinska Hospital and Institute
(P 270) FEASIBILITY OF FERTILITY PRESERVATION IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH SARCOMAS - A PROSPECTIVE COHORT STUDY WITH LONG-TERM FOLLOW-UP
Christina Linder-Stragliotto
Favorite
Lind, Meredith

Department of Otolaryngology, Nationwide Children's Hospital; Department of Otolaryngology, The Ohio State University College of Medicine
(P 264) RARE CASE OF INFLAMMATORY MYOFIBROBLASTIC TUMOR (IMT) IN NEWBORN
Meredith Lind
Favorite
Lindner, Lars H.

Department of Medicine III, LMU University Hospital, Munich, Germany
(P 64) ATRX EXPRESSION CORRELATES WITH REDUCED IMMUNE CHECKPOINT EXPRESSION AND POOR SURVIVAL IN HIGH-RISK SOFT TISSUE SARCOMAS
Lars H. Lindner
Favorite
(P 436) SAKK 57/24 FEASIBILITY OF TOTAL NEOADJUVANT TREATMENT WITH HYPERTHERMIA IN PATIENTS WITH HIGH-RISK EXTREMITY AND TRUNK SOFT TISSUE SARCOMA. A MULTICENTER, SINGLE ARM, OPEN LABEL, PHASE II TRIAL
Lars H. Lindner
Favorite
(P 437) CLINICAL DATA CONFIRM GALENIC PRINCIPLE AND DEMONSTRATE THERAPEUTIC POTENTIAL OF THE001 (DPPG2-TSL-DOX) PLUS REGIONAL HYPERTHERMIA IN SOFT TISSUE SARCOMA
Lars H. Lindner
Favorite
(P 443) FIRST-LINE PAZOPANIB IN PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Lars H. Lindner
Favorite
Lindsay, Sarah

Mount Sinai Hospital
(P 93) INTERCALARY COMPRESSIVE OSSEOINTEGRATION OF DIAPHYSEAL TUMORS: A MULTI-INSTITUTIONAL CASE SERIES
Sarah Lindsay
Favorite
(P 364) TRENDS IN SURGICAL MANAGEMENT OF DESMOID TUMOR IN THE VETERANS AFFAIRS (VA) NATIONAL DATABASE
Sarah Lindsay
Favorite
Lingad, Allyssa

Sarcoma Oncology Center
(P 233) DNG64-CAR-V+ REGIMEN SHOWS CLINICAL BENEFIT IN PATIENTS WITH ADVANCED CCNG1 ONCOGENE EXPRESSING SARCOMAS (NCT04091295)
Allyssa Lingad
Favorite
(P 388) TRIAL IN PROGRESS: A PHASE 2 STUDY OF METRONOMIC TRABECTEDIN, GEMCITIBAINE, AND DACARBAZINE IN PREVIOUSLY TREATED ADVANCED SOFT TISSUE SARCOMA (NCT04535271)
Allyssa Lingad
Favorite
(P 396) EVALUATING THE SAFETY AND EFFICACY OF METRONOMIC GEMCITABINE, DOXORUBICIN, AND DOCETAXEL PLUS NIVOLUMAB IN PREVIOUSLY TREATED ADVANCED LEIOMYOSARCOMA AND LIPOSARCOMA: A PHASE 2 STUDY (NCT04535713)
Allyssa Lingad
Favorite
Lin, Heather

MD Anderson Cancer Center
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Heather Lin
Favorite
Lin, Jessica

Massachusetts General Hospital
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Jessica Lin
Favorite
Lin, Jiahui

Sun Yat-sen University
(P 193) CLINICAL ANALYSIS OF RIPRETINIB DOSE ESCALATION IN ADVANCED GISTS AFTER STANDARD DOSE PROGRESSION
Jiahui Lin
Favorite
Lin, Miranda

Mayo Clinic
(P 300) FEATURES AND OUTCOMES OF PATIENTS WITH GASTROINTESTINAL LEIYOMYOSARCOMA
Miranda Lin
Favorite
Lin, Xin

Duke University
(P 126) SINGLE-CELL RNA SEQUENCING AND PROTEOMIC SPATIAL PROFILING REVEAL COMPLEX TUMOR MICROENVIRONMENT AND NOVEL IMMUNE INTERACTIONS IN CHONDROSARCOMA
Xin Lin
Favorite
Lischke, Robert

Third Department of Surgery, 1st Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
(P 243) CLINICAL SIGNIFICANCE OF TUMOR-INFILTRATING IMMUNE CELL SUBSETS IN THE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMAS AND LEIOMYOSARCOMAS
Robert Lischke
Favorite
Li, Shu

Department of Bone and Soft Tissue Tumour, Peking University Cancer Hospital, Beijing, China
(P 361) PEXIDARTINIB FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMORS: CLINICAL EXPERIENCE FROM FIVE CHINESE PATIENTS
Shu Li
Favorite
Li, Tao

Zhejiang Cancer Hospital
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Tao Li
Favorite
Litière, Saskia

European Organisation for Research and Treatment of Cancer
(P 456) OUTCOMES OF FIRST-LINE CHEMOTHERAPY IN ADVANCED ADULT-TYPE RHABDOMYOSARCOMAS: POOLED ANALYSIS OF CLINICAL TRIALS FROM THE EORTC SOFT TISSUE AND BONE SARCOMA GROUP
Saskia Litière
Favorite
Littleford, Hana

Rare Cancer Research Foundation
(P 350) THE PATTERN.ORG SARCOMA CONSORTIUM: BUILDING A MULTI-INSTITUTIONAL DATA RESOURCE FOR THE SARCOMA RESEARCH COMMUNITY
Hana Littleford
Favorite
Liu, Kevin

Massachusetts General Hospital
(P 290) CLINICAL OUTCOMES AFTER RADIOTHERAPY FOR PATIENTS WITH POORLY DIFFERENTIATED CHORDOMA
Kevin Liu
Favorite
(P 461) A RETROSPECTIVE ANALYSIS OF PATIENTS WITH CONVENTIONAL CHORDOMA TREATED WITH SYSTEMIC THERAPY
Kevin Liu
Favorite
Liu, Kunpeng

Department of Anesthesiology, Peking University International Hospital
(P 305) COMPARISON OF GOAL-DIRECTED VERSUS EMPIRICAL TRANSFUSION MANAGEMENT IN PATIENTS WITH SEVERE HEMORRHAGE DURING RETROPERITONEAL TUMOR SURGERY
Kunpeng Liu
Favorite
(P 469) THE IMPACT OF PREOPERATIVE ANEMIA ON POSTOPERATIVE COMPLICATIONS AND SHORT-TERM PROGNOSIS IN RETROPERITONEAL TUMOR SURGERY PATIENTS.
Kunpeng Liu
Favorite
Liu, Marion

Memorial Sloan Kettering Cancer Center
(P 186) BRAF V600E-MUTATED GASTROINTESTINAL STROMAL TUMORS: A CASE SERIES AND ANALYSIS OF IMMUNE TUMOR INFILTRATE
Marion Liu
Favorite
(P 187) THERAPEUTIC OUTCOMES IN NF1-ALTERED GIST TREATED WITH MEK INHIBITION: A SINGLE-CENTER EXPERIENCE
Marion Liu
Favorite
Liu, Minetta

Natera
(P 04) EARLY ON-TREATMENT CIRCULATING TUMOR DNA DYNAMICS TO PREDICT RESPONSE IN PATIENTS WITH SARCOMA
Minetta Liu
Favorite
Liu, Natalie

Surgical Oncology, Department of Surgery, University of California, Davis
(P 244) INTRATUMORAL TIGIT BLOCKADE AUGMENTS ANTI-TUMOR RESPONSES AND BYPASSES HYPERFUNCTIONALITY OF PERIPHERAL TIGIT+ NK CELLS IN MOUSE AND HUMAN MODELS OF BONE AND SOFT TISSUE SARCOMA
Natalie Liu
Favorite
Liu, Tang

The Second Xiangya Hospital of Central South University
(P 407) PIMICOTINIB IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): LONG-TERM EFFICACY, SAFETY, AND PATIENT-REPORTED OUTCOMES FROM THE PHASE 3 MANEUVER STUDY
Tang Liu
Favorite
Liu, Tracy

West Virginia University School of Medicine, Department of Microbiology, Immunology, and Cell Biology
(P 30) MYELOPEROXIDASE AS A POTENTIAL THERAPEUTIC TARGET IN SOFT TISSUE SARCOMA
Tracy Liu
Favorite
Liu, Xingliang

Providence Cancer Institute
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Xingliang Liu
Favorite
Liu, Yanghan

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Yanghan Liu
Favorite
Livergant, Rachel

University of British Columbia
(P 196) SURVEILLANCE STRATEGIES AND LONG-TERM OUTCOMES IN LOW-RISK GASTRIC GASTROINTESTINAL STROMAL TUMORS (GGISTS)
Rachel Livergant
Favorite
Livingston, Andrew

Departments of Sarcoma Medical Oncology and Paediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX, USA
(P 83) OUTCOMES OF MULTIMODAL PERIOPERATIVE TREATMENT IN OSTEOSARCOMAS OF THE JAW
Andrew Livingston
Favorite
(P 411) TFCP2 FUSION-POSITVE RHABDOMYOSARCOMAS: A REPORT OF 10 CASES AND A REVIEW OF THE LITERATURE
Andrew Livingston
Favorite
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Andrew Livingston
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Andrew Livingston
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Andrew Livingston
Favorite
Livingstone, Alan

University of Miami Hospital, Department of Surgical Oncology
(P 201) METASTATIC PATTERNS, TREATMENT MODALITIES, AND OVERALL SURVIVAL IN OLIGOMETASTATIC GIST: A SINGLE-CENTER RETROSPECTIVE STUDY
Alan Livingstone
Favorite
Li, William

University of Pittsburgh Medical Center
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
William Li
Favorite
Li, Yi

University of Texas at Dallas
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
Yi Li
Favorite
Li, Zola Chia-Chen

National Taiwan University Cancer Center
(P 428) MAINTENANCE PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS ACTIVE SURVEILLANCE FOR ADVANCED SOFT TISSUE SARCOMA PATIENTS WHO HAD CONTROLLED DISEASE AFTER STANDARD ANTHRACYCLINE-BASED TREATMENT (MELODY)
Zola Chia-Chen Li
Favorite
Ljungberg, Emil

University of Florida
(P 275) NEXT GENERATION SEQUENCING IN ADOLESCENT AND YOUNG ADULT (AYA) SARCOMAS: CLINICAL IMPACT, DIAGNOSTIC UTILITY, AND IMPLICATIONS
Emil Ljungberg
Favorite
Lobmaier, Ingvild Victoria Koren

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Ingvild Victoria Koren Lobmaier
Favorite
Locker, Amanda

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Amanda Locker
Favorite
(P 63) EVALUATING SURGICAL MARGINS IN SARCOMA RESECTION WITH INDOCYANINE GREEN FLUORESCENCE IMAGING
Amanda Locker
Favorite
(P 80) UTILIZATION OF THE MUSCULOSKELETAL ONCOLOGY TUMOR REGISTRY AND TISSUE BANK (MOTOR) FOR THE ACCELERATION OF SARCOMA RESEARCH
Amanda Locker
Favorite
Lock, Richard

Children's Cancer Institute Australia
(P 267) THE RAF/MEK INHIBITOR VS-6766 SHOWS EFFICACY IN RAS-MUTANT PEDIATRIC PRECLINICAL XENOGRAFT MODELS- A REPORT FROM THE PEDIATRIC PRECLINICAL IN VIVO TESTING CONSORTIUM
Richard Lock
Favorite
Loggers, Elizabeth

Fred Hutchinson Cancer Center
(P 287) A PHASE 1 STUDY OF NEOADJUVANT CABOZANTINIB IN COMBINATION WITH RADIATION THERAPY FOR SARCOMAS OF THE EXTREMITIES
Elizabeth Loggers
Favorite
(P 315) ANALYSIS OF CHANGES IN T2-WEIGHTED SIGNAL INTENSITY AND TUMOR VOLUME AND EXPOSURE-RESPONSE IN THE RINGSIDE PHASE 2 STUDY OF VAREGACESTAT FOR DESMOID TUMORS
Elizabeth Loggers
Favorite
(P 410) SUBGROUP ANALYSIS OF THE PHASE 2 PART OF THE RINGSIDE PHASE 2/3 TRIAL OF VAREGACESTAT FOR TREATMENT OF DESMOID TUMORS
Elizabeth Loggers
Favorite
(P 416) A PHASE 2 MULTICENTER OPEN-LABEL BASKET STUDY OF TAZEMETOSTAT IN ADULT PATIENTS WITH INI1-NEGATIVE EPITHELIOID SARCOMA – FINAL ANALYSIS
Elizabeth Loggers
Favorite
Lohse, Ines

University of Pittsburgh
(P 14) EVALUATING THE COMBINATION OF DISULFIRAM AND ENZALUTAMIDE IN OSTEOSARCOMA
Ines Lohse
Favorite
(P 65) INVESTIGATING MACROPHAGE POPULATIONS IN PRIMARY AND METASTATIC SARCOMA SAMPLES
Ines Lohse
Favorite
(P 80) UTILIZATION OF THE MUSCULOSKELETAL ONCOLOGY TUMOR REGISTRY AND TISSUE BANK (MOTOR) FOR THE ACCELERATION OF SARCOMA RESEARCH
Ines Lohse
Favorite
Loidl, Verena

Sarcoma Patient Advocacy Global Network e.V.
(P 229) DETERMINANTS OF DIAGNOSTIC INTERVAL IN EPITHELIOID HEMANGIOENDOTHELIOMA: A LINEAR AND QUANTILE REGRESSION ANALYSIS OF PATIENT-REPORTED DATA FROM THE SPAGN GLOBAL SARCOMA DIAGNOSIS PATHWAY SURVEY
Verena Loidl
Favorite
Loidl, Verena

The EHE Foundation
(P 449) UNDERSTANDING GAPS IN KNOWLEDGE AND PATIENT-REPORTED PAIN IN EPITHELIOID HEMANGIOENDOTHELIOMA: RESULTS FROM A GLOBAL PATIENT REGISTRY
Verena Loidl
Favorite
Lombard, David

University of Miami Department of Pathology & Laboratory Medicine
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
David Lombard
Favorite
(P 60) EXPLORING METABOLIC REWIRING IN CHORDOMA
David Lombard
Favorite
(P 225) GLOBAL REGISTRY OF SOLITARY FIBROUS TUMORS (SFT): INTEGRATING CLINICAL, MOLECULAR, AND ENVIRONMENTAL DATA- THE HOROWITZ SFT INITIATIVE (HSFTI)
David Lombard
Favorite
(P 253) ELUCIDATING THE ROLE OF SIRT7 IN EWING SARCOMA
David Lombard
Favorite
(P 369) CLINICAL CHARACTERISTICS & TREATMENT OUTCOME PATTERNS OF SOLITARY FIBROUS TUMORS: A SINGLE-INSTITUTION RETROSPECTIVE ANALYSIS
David Lombard
Favorite
(P 393) DISTINCT SECONDARY MUTATIONAL LANDSCAPES ARE ASSOCIATED WITH NAB2–STAT6 FUSION BREAKPOINTS IN SOLITARY FIBROUS TUMORS
David Lombard
Favorite
(P 462) HDAC INHIBITORS AS POTENTIAL SFT THERAPIES
David Lombard
Favorite
London, Wendy

Boston Children's Hospital / Dana-Farber Cancer Institute
(P 427) PHASE 1/2 TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF PEEL-224 IN COMBINATION WITH VINCRISTINE AND TEMOZOLOMIDE IN ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED OR REFRACTORY SARCOMAS
Wendy London
Favorite
Longaker, Michael

Stanford University
(P 37) DISSECTING THE TUMOR MICROENVIRONMENT OF UTERINE LEIOMYOSARCOMAS FOR TARGETED DRUG PREDICTIONS
Michael Longaker
Favorite
Long, Georgina

Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, and Mater and Royal North Shore Hospitals
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Georgina Long
Favorite
Lopes, Ademar

A.C.Camargo Cancer Center
(P 278) NEOADJUVANT HYPOFRACTIONATED RADIOTHERAPY AND CHEMOTHERAPY IN EXTREMITY SOFT TISSUE SARCOMAS
Ademar Lopes
Favorite
Lopes, Carlos

Princess Margaret Cancer Centre, Mount Sinai Hospital, University of Toronto
(P 395) ERIBULIN IN RECURRENT PRETREATED METASTATIC SOFT TISSUE SARCOMA. A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) REAL WORLD ANALYSIS
Carlos Lopes
Favorite
Lopez Saavedra, Alejandro

Instituto Nacional de Cancerología
(P 39) BUB1 AN OVEREXPRESSED KINASE IN SARCOMA: FINDING NEW TARGET THERAPY FOR OSTEOSARCOMA, LIPOSARCOMA, SYNOVIAL SARCOMA AND LEIOMYOSARCOMA
Alejandro Lopez Saavedra
Favorite
Lopez, Ann

Clear Cell Sarcoma Foundation
(P 450) OUTCOMES IN CLEAR CELL SARCOMA: UPDATED INSIGHTS FROM ELECTRONIC HEALTH RECORDS IN A PATIENT-LED REGISTRY
Ann Lopez
Favorite
López-Jiménez, Carlos

Hospital Universitario Fundación Jiménez Díaz. Instituto de Investigación Sanitaria FJD-UAM.
(P 356) DESMOID TUMORS: A RETROSPECTIVE ANALYSIS FROM A REFERRAL CENTER
Carlos López-Jiménez
Favorite
(P 389) UNRESECTABLE AND METASTATIC DEDIFFERENTIATED LIPOSARCOMA (DDLPS): INSIGHTS FROM A MULTICENTER REAL-WORLD COHORT (RWC)
Carlos López-Jiménez
Favorite
Lopez-Marti, Jesus

Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz
(P 38) VALIDATION OF THE SIGNIOS SEVEN-GENE SIGNATURE FOR PREDICTING ANTI-PD-1 INHIBITOR EFFICACY IN SARCOMA
Jesus Lopez-Marti
Favorite
Lorenzi, Luisa

University of Brescia and ASST Spedali Civili di Brescia
(P 458) BETWEEN LYMPHOMAS AND SARCOMAS: A RETROSPECTIVE, MULTI-INSTITUTIONAL STUDY FROM THE ITALIAN SARCOMA GROUP (ISG) ON HISTIOCYTIC AND DENDRITIC CELL NEOPLASMS (HDCN)
Luisa Lorenzi
Favorite
Lorenz, Susanne

Oslo University Hospital
(P 200) DISSECTING INTRATUMORAL HETEROGENEITY IN GIST USING SPATIAL TRANSCRIPTOMICS
Susanne Lorenz
Favorite
Louka, Jean

Department of Orthopaedics, University of Miami
(P 90) MEGAPROSTHESIS CONVERSION FROM FAILED OSTEOARTICULAR ALLOGRAFT VERSUS PRIMARY RECONSTRUCTION FOR DISTAL FEMUR AND PROXIMAL TIBIA TUMORS: A PROPENSITY MATCHED-PAIR ANALYSIS
Jean Louka
Favorite
Louka, Jean G.

Department of Orthopaedics, University of Miami
(P 89) PATELLAR HEIGHT AND ITS INFLUENCE ON FUNCTIONAL OUTCOMES FOR MEGAPROSTHESES AROUND THE KNEE PERFORMED FOR ONCOLOGICAL INDICATIONS
Jean G. Louka
Favorite
Lovell, Timothy

Peter MacCallum Cancer Centre
(P 344) REAL-WORLD EXPERIENCE OF SORAFENIB IN DESMOID TUMOURS: A SINGLE-CENTRE AUSTRALIAN STUDY
Timothy Lovell
Favorite
Low, Gill

Precision for Medicine
(P 431) INVOKE: A PHASE 1 STUDY OF OKN4395, A FIRST-IN-CLASS EP2/EP4/DP1 TRIPLE PROSTANOID RECEPTOR ANTAGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, INCLUDING SARCOMAS
Gill Low
Favorite
Lowney, Rachael

NCI/NIH
(P 181) THE DEVELOPMENT OF A NOVEL PDGFRA RESISTANCE MUTATION IN A RECURRENT KIT-MUTANT GASTROINTESTINAL STROMAL TUMOR (GIST)
Rachael Lowney
Favorite
Lozano Calderon, Santiago

Massachusetts General Hospital Department of Orthopaedic Surgery
(P 17) EXTRASKELETAL OSTEOSARCOMA: MICRORNA PATTERNS PROVIDE INSIGHTS INTO SIMILARITIES AND CONTRASTS WITH OTHER SARCOMAS
Santiago Lozano Calderon
Favorite
(P 62) INTRAOPERATIVE BONE AND SOFT TISSUE TUMOR MARGIN IDENTIFICATION WITH FLUORESCENCE LIFETIME (FLT) IMAGING
Santiago Lozano Calderon
Favorite
(P 87) ACUTE PATHOLOGICAL LONG BONE FRACTURES: WEEKEND VERSUS WEEKDAY VARIATIONS AND THEIR CLINICAL IMPACT
Santiago Lozano Calderon
Favorite
(P 91) A COMPARISON OF ACETABULAR AUGMENTATION AND PHOTODYNAMIC NAIL STABILIZATION FOR COMPLEX ONCOLOGIC TOTAL HIP ARTHROPLASTY
Santiago Lozano Calderon
Favorite
(P 98) PERCUTANEOUS STABILIZATION OF METASTATIC BONE LESIONS WITH A PHOTODYNAMIC INTRAMEDULLARY SYSTEM: EXPERIENCE FROM A 15-PATIENT CASE SERIES
Santiago Lozano Calderon
Favorite
(P 105) TREATMENT SUCCESS RATE AFTER SURGICAL MANAGEMENT OF PERIPROSTHETIC JOINT INFECTIONS IN ONCOLOGIC PROXIMAL TIBIA RECONSTRUCTION
Santiago Lozano Calderon
Favorite
(P 112) PEDIATRIC GIANT CELL TUMOR OF BONE
Santiago Lozano Calderon
Favorite
(P 118) IMPACT OF TYROSINE KINASE INHIBITOR THERAPY ON BONE PROGRESSION IN PATIENTS WITH DRIVER-MUTATED METASTATIC NON-SMALL CELL LUNG CANCER WITH DE NOVO BONE METASTASES
Santiago Lozano Calderon
Favorite
(P 151) SHOULD WE USE ADJUVANT CHEMOTHERAPY IN PATIENTS WITH LOCALIZED DEDIFFERENTIATED CHONDROSARCOMA (DDCS) OF THE PELVIS? AN ANALYSIS BY THE PELVIC DDCS STUDY GROUP
Santiago Lozano Calderon
Favorite
(P 173) DEVELOPMENT AND EXTERNAL VALIDATION OF A MACHINE LEARNING ALGORITHM TO PREDICT OVERALL SURVIVAL IN PATIENTS WITH PELVIC OR APPENDICULAR LIPOSARCOMA
Santiago Lozano Calderon
Favorite
(P 174) BIAS OR BEST FIT? A COMPARATIVE ANALYSIS OF SEER AND NCDB DATASETS IN SINGLE MODEL MACHINE LEARNING FOR PREDICTING OSTEOSARCOMA SURVIVAL OUTCOMES
Santiago Lozano Calderon
Favorite
(P 205) CENTRALIZATION OF SARCOMA CARE IMPROVES OUTCOMES DESPITE POORER PRESENTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Santiago Lozano Calderon
Favorite
(P 294) RISK FACTORS FOR RECURRENCE AND COMPLICATIONS OF CT-GUIDED RADIOFREQUENCY ABLATION FOR THE TREATMENT OF OSTEOID OSTEOMA: A MULTI-INSTITUTIONAL ANALYSIS.
Santiago Lozano Calderon
Favorite
(P 375) DOES STAGED RESECTION WITH TEMPORIZING WOUND VACUUM INFLUENCE LOCAL RECURRENCE RISK? A MULTI-INSTITUTIONAL MATCHED COHORT ANALYSIS
Santiago Lozano Calderon
Favorite
(P 392) CLASSIFICATION AND DIFFERENTIATIONOF MYXOID LIPOSARCOMA AND MYXOMA WITH MACHINE LEARNING
Santiago Lozano Calderon
Favorite
(P 392) DIFFERENTIATION OF MYXOMA AND MYXOID LIPOSARCOMA BASED ON RADIOMICS PHENOTYPES
Santiago Lozano Calderon
Favorite
(P 402) LYMPH NODE METASTASES IN SOFT TISSUE SARCOMA: A DATABASE ANALYSIS
Santiago Lozano Calderon
Favorite
Lozza, Laura

Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan
(P 277) THE ROLE OF RADIOTHERAPY IN THE MULTIDISCIPLINARY MANAGEMENT OF RADIATION-ASSOCIATED ANGIOSARCOMA OF THE BREAST: A REFERRAL CENTER EXPERIENCE
Laura Lozza
Favorite
Lucarelli, Enrico

IRCCS Rizzoli Orthopaedic Institute
(P 18) ESTABLISHMENT AND CHARACTERIZATION OF A NOVEL PRIMARY CELL LINE FROM A BONE METASTASIS OF OSTEOSARCOMA
Enrico Lucarelli
Favorite
Ludwig, Joseph

MD Anderson Cancer Center
(P 22) SINGLE CELL SEQUENCING ENABLES LINEAGE-INFORMED TARGETING OF OSTEOSARCOMA
Joseph Ludwig
Favorite
(P 47) EWSR1::WT1 FUSION ONCOPROTEIN ACTIVITY SHAPES LINEAGE HETEROGENEITY IN DESMOPLASTIC SMALL ROUND CELL TUMORS
Joseph Ludwig
Favorite
(P 451) TREATMENT OUTCOMES OF GEMCITABINE AND DOCETAXEL IN PATIENTS WITH CLEAR CELL SARCOMA (CCS) OR GASTROINTESTINAL NEUROECTODERMAL TUMOR (GNET): A CASE SERIES
Joseph Ludwig
Favorite
(P 460) OUTCOMES OF LATER-LINES SYSTEMIC THERAPIES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)
Joseph Ludwig
Favorite
Luen, Stephen

Peter MacCallum Cancer Centre
(P 121) REAL-WORLD EXPERIENCE OF CABOZANTINIB MONOTHERAPY IN RELAPSED OR REFRACTORY OSTEOSARCOMA AND EWING SARCOMA: A SINGLE-CENTRE AUSTRALIAN STUDY
Stephen Luen
Favorite
Lu, Hui

Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Hui Lu
Favorite
Luke, Jason

Strand Therapeutics Inc.
(P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS
Jason Luke
Favorite
(P 440) CASE REPORT: COMPLETE CLINICAL AND MOLECULAR RESPONSE TO INTRATUMORAL STX-001, AN LNP-SELF REPLICATING MRNA EXPRESSING IL-12 IN A PATIENT WITH REFRACTORY ANGIOSARCOMA
Jason Luke
Favorite
Lu, Lin

Memorial Sloan Kettering Cancer Center
(P 273) RADIOMIC PREDICTORS OF SPONTANEOUS PNEUMOTHORAX DURING TYROSINE KINASE INHIBITOR THERAPY FOR LUNG METASTASES
Lin Lu
Favorite
Lum, Deirdre

Stanford University
(P 68) MULTI-OMIC INTRA- AND INTER-TUMOR HETEROGENEITY OF BENIGN SMOOTH MUSCLE TUMORS
Deirdre Lum
Favorite
Luna Hurtado, Hernán Camilo

Fundación Colombiana de Cancerología Clínica Vida
(P 219) RETROPERITONEAL SARCOMA: HEALTH SYSTEM BARRIERS AND THE RATIONALE FOR A SPECIALIZED SARCOMA UNIT
Hernán Camilo Luna Hurtado
Favorite
(P 301) RETROPERITONEAL SARCOMA: SINGLE CENTER EXPERIENCE IN LATIN AMERICA. DO WE HAVE DIFFERENT SARCOMAS WHEN COMPARED TO THE REST OF THE WORLD?
Hernán Camilo Luna Hurtado
Favorite
Luna-Ortiz, Kuauhyama

National Cancer Institute Mexico
(P 302) PREDICTORS AND OUTCOMES OF RECURRENT RETROPERITONEAL SARCOMA: A SINGLE-CENTER LATIN AMERICAN COHORT STUDY
Kuauhyama Luna-Ortiz
Favorite
Luna, Pablo

Hospital Universitari Son Espases
(P 71) GERMLINE POLYMORPHISMS IN THE VEGF PATHWAY AS PROGNOSTIC BIOMARKERS IN LOCALIZED HIGH-GRADE OSTEOSARCOMA: A STUDY BASED ON DATA FROM THE GEIS-33 PROTOCOL
Pablo Luna
Favorite
Lundin, Mia

University of Colorado Department of Orthopedics
(P 268) QUALITY OF LIFE OUTCOMES IN PEDIATRIC PATIENTS UNDERGOING SURGICAL INTERVENTION FOR LOWER EXTREMITY BONE SARCOMAS
Mia Lundin
Favorite
Lunec, John

Newcastle University
(P 133) INVESTIGATION OF COMBINING MDM2 INHIBITORS WITH DR5 AGONISTS FOR BONE SARCOMA TREATMENT
John Lunec
Favorite
Luo, Lixia

Duke University Medical Center
(P 58) PLK1 AS A VULNERABLE TARGET OF BAP1-DRIVEN UNDIFFERENTIATED PLEOMORPHIC SARCOMAS
Lixia Luo
Favorite
Luo, Tim

University of Calgary
(P 293) CRYOABLATION FOR EXTRA-ABDOMINAL DESMOID TUMORS: A RETROSPECTIVE STUDY OF RADIOLOGIC AND CLINICAL OUTCOMES
Tim Luo
Favorite
Luo, Wen

New York Medical College
(P 76) CD47 BLOCKADE SYNERGIZES WITH CHEMOTHERAPY IN ENHANCING MACROPHAGE PHAGOCYTOSIS OF EWING SARCOMA CELLS
Wen Luo
Favorite
Lu, Qiang

Deciphera Pharmaceuticals, LLC
(P 358) EFFECT OF A HIGH-FAT MEAL ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR (CSF1R), IN HEALTHY PARTICIPANTS
Qiang Lu
Favorite
(P 376) EFFECT OF ITRACONAZOLE (ITZ) AND RABEPRAZOLE (RBP) ON THE PHARMACOKINETICS (PK) OF VIMSELTINIB, AN ORAL INHIBITOR OF THE COLONY-STIMULATING FACTOR 1 RECEPTOR, IN HEALTHY PARTICIPANTS
Qiang Lu
Favorite
Lurie, Eugene

Pyxis Oncology
(P 29) ANTI-TUMOR ACTIVITY OF MICVOTABART PELIDOTIN IS ASSOCIATED WITH ENZYME GENE EXPRESSION IN PATIENT-DERIVED XENOGRAFT SARCOMA MODELS
Eugene Lurie
Favorite
Lu, Sally

University of Florida
(P 401) LONG-TERM OUTCOMES OF IMATINIB-TREATED DERMATOFIBROSARCOMA PROTUBERANS: INSIGHTS FROM A SINGLE-INSTITUTION CASE SERIES
Sally Lu
Favorite
Luu, Thao

Deciphera Pharmaceuticals, LLC
(P 195) IMPACT OF EXPERT-LED EDUCATION PROGRAMS ON HEALTH CARE PROVIDER (HCP) KNOWLEDGE OF GASTROINTESTINAL STROMAL TUMOR (GIST)
Thao Luu
Favorite
Lv, Yu

Department of Orthopaedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
(P 07) A LIVING MULTI-OMICS BIOBANK OF PATIENT-DERIVED XENOGRAFT MODELS FOR SARCOMA
Yu Lv
Favorite
Lydon, Nicholas

IDRx
(P 194) UPDATED RESULTS FROM STRATEGIST 1: A PHASE 1/1B STUDY OF IDRX-42 (GSK6042981A) IN PATIENTS (PTS) WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST)
Nicholas Lydon
Favorite
Lyssiotis, Costas

University of Michigan
(P 24) THE SIRTUIN SIRT5 SUPPORTS EWING SARCOMA SURVIVAL VIA REGULATION OF EWS-FLI1 STABILITY AND ACTIVITY
Costas Lyssiotis
Favorite
Lyu, Heather

MD Anderson Cancer Center
(P 351) THE ROLE OF SOCIOECONOMIC DISPARITIES ON SURVIVAL OUTCOMES IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Heather Lyu
Favorite